Navigation Links
Cologne mycology professor Oliver Cornely honored with 'Prof Pushpa Talwar Memorial Oration'
Date:1/17/2014

Cologne, 17 January 2014. Prof Cornely heads the Clinical Trials Center and the Translational Research Platform at the CECAD Excellence Cluster at the University of Cologne. In addition to his research activities, as a senior physician at the Clinic I of Internal Medicine of the Cologne University Hospital he is responsible for clinical therapies for mycological infections. Prof Cornely's research focuses on the prevention and treatment of fungal diseases. His clinical studies and research are highly relevant to both individuals and society as a whole, since invasive fungal infections have a mortality rate of up to 80 percent. This area of medical research has important implications for India.

Together with his Cologne working group, Prof Cornely developed the first prophylaxis against fungal infection and successfully demonstrated the effectiveness of high-dose therapies for patients already infected. His guidelines for treating mucormycoses, which are the first in the world, will serve as a foundation for additional standard treatments in India where infections caused by mucor fungi are common. Prof Cornely's findings are also internationally highly relevant for cancer therapies; Immune systems of cancer patients are often compromised by treatment which increases the risk of fungal infection. One of Cornely's current studies explores the fungal infection risk for leukaemia patients, for example.

Prof Cornely's mycology research is a very valued element of the aging research carried out at the CECAD Excellence Cluster as well. Our immune systems weaken as we age, which increases the risk of fungal infection.

The prize is bestowed by the Post Graduate Institute of Medical Education and Research (PGIMER). Founded as a centre for excellence in medical science in 1960, it is one of the two most important medical institutes in India.

Recipients are honoured for their exceptional excellence in medical mycology. The award was named after Prof Pushpa Talwar, an accomplished researcher in mycology over many years who founded an independent mycology department during her tenure at PGIMER that has since grown into a national reference laboratory. The first memorial oration was delivered in 2012 to Dr Jacques F. Meis from the Canisius Wilhelm Hospital in Nijmegen, Netherlands.

The prize promotes mycological research and was established in memory of Prof Pushpa Talwar, the former Director of the Medical Mycology Department at PGIMER and honorary member of the Society of Indian Human and Animal Mycologists.


'/>"/>

Contact: Prof Oliver Cornely
Oliver.cornely@zks-koeln.de
49-022-147-888-794
University of Cologne
Source:Eurekalert

Related medicine news :

1. Louisiana Tech University professor earns NSF Early Career Development grant
2. Clemson professor awarded nearly $600,000 4-year grant to study language of plants
3. Louisiana Tech biomedical engineering professor earns recognition, funding for research
4. Women professorships low in some Scandinavian universities due to sexism
5. President Obama names SF State math professor a top young scientist
6. From textbook to flexbook: Professor uses new collaborative tool in the classroom
7. IHME professor named first health measurement winner of prestigious innovation award
8. Guys, take note: Male birth control pill may be ready soon, says Texas A&M professor
9. UBC professor wins Canadas top pharmaceutical research award
10. Huddersfield professors ground-breaking research shows just how well the 2012 Games were run
11. Grove Professor receives $1.5MM to study breast cancer therapies
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/25/2017)... (PRWEB) , ... July 25, 2017 , ... Facing medical ... father Ezra Clark is taking advantage of a new benefit for employees that is ... means a lot that the company supports me and other employees as new parents. ...
(Date:7/24/2017)... ... July 24, 2017 , ... ...      (407) 916-7235, kklaproth(at)robinsmorton(dot)com , Robins & Morton, Perkins Will, ... celebrate the structural topping out of the new Destination Medical Building located ...
(Date:7/24/2017)... TX (PRWEB) , ... July 24, 2017 , ... ... under the federal Substance Abuse and Mental Health Services Administration’s (SAMHSA) State Targeted ... of California Department of Health Care Services, will facilitate the development of a ...
(Date:7/24/2017)... ... ... The International Essential Tremor Foundation (IETF) will host a free educational forum in ... take place on Saturday, Aug. 26 at the Embassy Suites by Hilton Cleveland Rockside ... a.m. to 12 p.m., with check-in beginning at 8 a.m. The event is sponsored ...
(Date:7/24/2017)... ... July 24, 2017 , ... ... already work hand-in-hand on an Innovation Collaboration program, have signed a five-year agreement ... and cost of the care members and patients receive. The agreement also signifies ...
Breaking Medicine News(10 mins):
(Date:7/10/2017)... GAITHERSBURG, Md. , July 10, 2017 ... in non-animal test methods, is the recipient of a ... by the PETA International Science Consortium. The device, which ... be used to expose human lung cells to airborne ... lung. IIVS will use the VITROCELL® system for testing ...
(Date:7/10/2017)... July 10, 2017 Locus Biosciences Inc. today ... support the development of CRISPR-Cas3 antimicrobial therapeutics. Financing for ... leading Chinese Internet services provider, and joined by the ... infectious disease product programs targeting antibiotic resistant infections and ... Founded by Dr. Rodolphe Barrangou and Dr. ...
(Date:7/5/2017)... , July 5, 2017 ... www.oramed.com ), a clinical-stage pharmaceutical company focused ... that it has received approval from the Israel Securities Authority ... Exchange (TASE). Oramed common stock will commence trading on the ... on the current market capitalization of the Company, it is ...
Breaking Medicine Technology: